Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto‐GBG 84 Trial

BACKGROUND: Patients with breast cancer can be affected by cardiotoxic reactions through cancer therapies. Cardiac biomarkers, like NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) and high‐sensitivity cardiac troponin T, might have predictive value. METHODS AND RESULTS: Echocardiography, ECG,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rüger, Alexandra Maria, Schneeweiss, Andreas, Seiler, Sabine, Tesch, Hans, van Mackelenbergh, Marion, Marmé, Frederik, Lübbe, Kristina, Sinn, Bruno, Karn, Thomas, Stickeler, Elmar, Müller, Volkmar, Schem, Christian, Denkert, Carsten, Fasching, Peter A., Nekljudova, Valentina, Garfias‐Macedo, Tania, Hasenfuß, Gerd, Haverkamp, Wilhelm, Loibl, Sibylle, von Haehling, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763783/
https://www.ncbi.nlm.nih.gov/pubmed/33191846
http://dx.doi.org/10.1161/JAHA.120.018143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7763783/
https://www.ncbi.nlm.nih.gov/pubmed/33191846
http://dx.doi.org/10.1161/JAHA.120.018143

Ejemplares similares